By Cristina Gallardo
Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish pharmaceutical company--about a possible deal.
"Brookfield is not, and has not been, in discussions with the company's board of directors with respect to a potential transaction," Brookfield said.
The investor said it maintains a general dialogue with Grifols's reference shareholders, but said there is no update since it decided against making a bid for the company in November.
Grifols's board said separately that it "has no knowledge" of talks regarding another attempt by Brookfield to acquire the company.
The statements came after Spanish news website El Confidencial reported, citing unnamed sources, that Brookfield had resumed talks with the Grifols family over a possible deal.
Shares in Grifols traded 6% higher at 8.63 euros in European afternoon trading, paring back gains of as much as 15% earlier in the session, after both Grifols and Brookfield issued their statements.
Write to Cristina Gallardo at cristina.gallardo@wsj.com
(END) Dow Jones Newswires
April 02, 2025 08:47 ET (12:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。